| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2005;46:932.)
© 2005 American Heart Association, Inc.
Part 2 Original Articles |
From the Laboratory of Transgenes and Cardiovascular Control (R.M.P.A., V.A.P. S.S.M., E.C.V.), Physiological Sciences Graduate Program, Biomedical Center, Federal University of Espirito Santo, Brazil; and College of Health Sciences of Vitoria (EMESCAM; E.C.V.), Vitoria, ES, Brazil.
Correspondence to Elisardo C. Vasquez, PhD, Physiological Sciences Graduate Program, CBM, UFES, Av. Marechal Campos 1468, Vitoria, Brazil 29042-755. E-mail evasquez{at}terra.com.br
It is known that the endothelial function is compromised in atherosclerosis and arterial hypertension and that angiotensin is an important factor contributing to both pathophysiologies. The aim of this study was to evaluate the vascular function in a hypercholesterolemia/atherosclerosis model, in the angiotensin IIdependent 2-kidney 1-clip (2K1C) hypertension model and when both conditions coexist. Eight-week-old apolipoprotein E knockout (apoE; n=20) and C57BL/6 (C57; n=20) mice underwent a 2K1C
Key Words: atherosclerosis mice hypertension, renovascular apolipoproteins mesenteric arteries mice
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |